Compare · SMTI vs ZBH
SMTI vs ZBH
Side-by-side comparison of Sanara MedTech Inc. (SMTI) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SMTI and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $19.12B, about 60.0x SMTI ($318.5M).
- Both names hit the wire about 7 times in the past 4 weeks.
- ZBH has more recent analyst coverage (25 ratings vs 6 for SMTI).
- Company
- Sanara MedTech Inc.
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $318.5M
- $19.12B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 7
- 7
- Recent ratings
- 6
- 25
Sanara MedTech Inc.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. It also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers; and PULSAR II Advanced Wound Irrigation System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest SMTI
- SEC Form 425 filed by Sanara MedTech Inc.
- SEC Form 10-Q filed by Sanara MedTech Inc.
- SEC Form 425 filed by Sanara MedTech Inc.
- Sanara MedTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
- SEC Form 425 filed by Sanara MedTech Inc.
- Amendment: Sanara MedTech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 425 filed by Sanara MedTech Inc.
- SEC Form 425 filed by Sanara MedTech Inc.
- SEC Form 425 filed by Sanara MedTech Inc.
Latest ZBH
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Grp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)
- UBS initiated coverage on Zimmer Biomet with a new price target
- SEC Form 3 filed by new insider Desai Chintan
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region